Swedbank AB Sells 24,062 Shares of Humana Inc. $HUM

Swedbank AB lowered its position in shares of Humana Inc. (NYSE:HUM) by 21.5% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 87,741 shares of the insurance provider’s stock after selling 24,062 shares during the quarter. Swedbank AB’s holdings in Humana were worth $15,213,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in the business. Sound View Wealth Advisors Group LLC raised its holdings in shares of Humana by 3.5% in the fourth quarter. Sound View Wealth Advisors Group LLC now owns 1,060 shares of the insurance provider’s stock valued at $272,000 after purchasing an additional 36 shares during the last quarter. CoreCap Advisors LLC boosted its holdings in Humana by 54.4% during the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 37 shares during the last quarter. Columbus Macro LLC grew its position in Humana by 5.5% in the fourth quarter. Columbus Macro LLC now owns 821 shares of the insurance provider’s stock valued at $210,000 after purchasing an additional 43 shares in the last quarter. Fiduciary Alliance LLC grew its position in Humana by 0.9% in the first quarter. Fiduciary Alliance LLC now owns 5,628 shares of the insurance provider’s stock valued at $976,000 after purchasing an additional 49 shares in the last quarter. Finally, Sanctuary Advisors LLC increased its stake in Humana by 1.6% in the 4th quarter. Sanctuary Advisors LLC now owns 3,389 shares of the insurance provider’s stock valued at $868,000 after buying an additional 52 shares during the last quarter. 92.38% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

HUM has been the topic of several analyst reports. Weiss Ratings raised shares of Humana from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, June 29th. Wells Fargo & Company downgraded Humana from a “cautious” rating to a “reduce” rating in a research report on Wednesday, May 20th. Bank of America upped their target price on Humana from $340.00 to $380.00 and gave the stock a “neutral” rating in a report on Wednesday, June 24th. Zacks Research raised Humana from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 13th. Finally, JPMorgan Chase & Co. raised their price target on Humana from $214.00 to $316.00 and gave the company a “neutral” rating in a research note on Monday, June 8th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, sixteen have assigned a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $303.74.

Humana Price Performance

Shares of NYSE HUM opened at $397.80 on Friday. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66. The business’s 50 day moving average price is $335.83 and its two-hundred day moving average price is $254.22. The company has a market cap of $47.76 billion, a PE ratio of 42.55, a price-to-earnings-growth ratio of 2.26 and a beta of 0.71. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $415.00.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. Humana had a return on equity of 10.45% and a net margin of 0.82%.The company had revenue of $39.65 billion during the quarter, compared to analysts’ expectations of $39.37 billion. During the same period last year, the firm posted $11.58 earnings per share. The business’s revenue was up 23.5% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000- EPS. On average, analysts predict that Humana Inc. will post 9.03 EPS for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Humana’s payout ratio is 37.86%.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.